APG Asset Management N.V. Acquires 69,500 Shares of The Clorox Company (NYSE:CLX)

APG Asset Management N.V. increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 204.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 103,500 shares of the company's stock after acquiring an additional 69,500 shares during the quarter. APG Asset Management N.V. owned about 0.08% of Clorox worth $16,233,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CLX. Abacus FCF Advisors LLC increased its holdings in shares of Clorox by 52.9% in the fourth quarter. Abacus FCF Advisors LLC now owns 16,838 shares of the company's stock worth $2,735,000 after purchasing an additional 5,824 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Clorox by 21.0% during the 4th quarter. Renaissance Technologies LLC now owns 697,967 shares of the company's stock valued at $113,357,000 after buying an additional 120,900 shares in the last quarter. Bank of Nova Scotia increased its stake in Clorox by 19.2% in the 4th quarter. Bank of Nova Scotia now owns 80,316 shares of the company's stock worth $13,044,000 after acquiring an additional 12,950 shares during the last quarter. FIL Ltd boosted its position in shares of Clorox by 78.0% during the 4th quarter. FIL Ltd now owns 3,159 shares of the company's stock valued at $513,000 after acquiring an additional 1,384 shares during the last quarter. Finally, Polymer Capital Management US LLC bought a new position in Clorox during the fourth quarter valued at $641,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Down 0.6 %

Shares of NYSE:CLX traded down $0.82 during trading on Tuesday, reaching $140.12. 225,156 shares of the company were exchanged, compared to its average volume of 1,295,229. The business's fifty day simple moving average is $147.29 and its 200-day simple moving average is $157.05. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market capitalization of $17.26 billion, a PE ratio of 38.28, a P/E/G ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the company posted $2.16 EPS. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.48%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Barclays decreased their target price on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research report on Friday. DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Citigroup decreased their price target on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a research note on Friday. Finally, StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Hold" and an average price target of $155.08.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.